SFRP4 and benign prostatic hyperplasia: Although there are several studies presenting genome wide methylation analysis of prostate cancer tissue22,40–43, few studies report on methylation of SFRP4. One study performed targeted methylation assays, but could not find any difference in methylation of the SFRP4 promotor when comparing normal, BPH and prostate cancer samples44.